Alyeska Investment Group, L.P. Royalty Pharma PLC Transaction History

Alyeska Investment Group, L.P.

$25 Billion
Q4 2024

A detailed history of Alyeska Investment Group, L.P. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 589,848 shares of RPRX stock, worth $19.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

589,848

Previous 589,848 -0.0%

Holding current value

$19.7 Million

Previous $16.7 Million 9.82%

% of portfolio

0.06%

Previous 0.09%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$25.63 - $29.27 $3.19 Million - $3.65 Million	-124,556 Reduced 17.43%	589,848 $16.7 Million
Q2 2024 Aug 14, 2024	SELL	$26.26 - $29.9 $11.5 Million - $13.1 Million	-437,367 Reduced 37.97%	714,404 $18.8 Million
Q1 2024 May 15, 2024	BUY	$27.46 - $31.33 $3.59 Million - $4.1 Million	130,735 Added 12.8%	1,151,771 $35 Million
Q4 2023 Feb 14, 2024	SELL	$26.21 - $29.22 $10.5 Million - $11.7 Million	-400,034 Reduced 28.15%	1,021,036 $28.7 Million
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $23.2 Million - $28.6 Million	782,676 Added 122.6%	1,421,070 $43.7 Million
Q1 2023 May 15, 2023	BUY	$32.77 - $39.4 $4.11 Million - $4.94 Million	125,367 Added 24.44%	638,394 $23 Million
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $20.1 Million - $22.6 Million	513,027 New	513,027 $20.3 Million
Q2 2022 Aug 15, 2022	BUY	$37.53 - $44.22 $10.6 Million - $12.4 Million	281,335 Added 383.32%	354,729 $14.9 Million
Q1 2022 May 16, 2022	SELL	$37.46 - $42.44 $1.93 Million - $2.19 Million	-51,606 Reduced 41.28%	73,394 $2.86 Million
Q3 2021 Nov 15, 2021	SELL	$36.14 - $42.24 $8.19 Million - $9.57 Million	-226,597 Reduced 64.45%	125,000 $4.52 Million
Q2 2021 Aug 16, 2021	BUY	$39.85 - $46.63 $996,250 - $1.17 Million	25,000 Added 7.65%	351,597 $14.4 Million
Q1 2021 May 17, 2021	SELL	$42.34 - $52.82 $18.5 Million - $23.1 Million	-437,220 Reduced 57.24%	326,597 $14.2 Million
Q4 2020 Feb 16, 2021	BUY	$36.12 - $50.05 $9.39 Million - $13 Million	260,082 Added 51.63%	763,817 $38.2 Million
Q3 2020 Nov 16, 2020	BUY	$38.56 - $48.36 $2.64 Million - $3.31 Million	68,540 Added 15.75%	503,735 $21.2 Million
Q2 2020 Aug 14, 2020	BUY	$44.5 - $52.11 $19.4 Million - $22.7 Million	435,195 New	435,195 $21.1 Million

Others Institutions Holding RPRX

# of Institutions

431

Shares Held

294M

Call Options Held

508K

Put Options Held

118K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $14.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.

Account

Alyeska Investment Group, L.P. Royalty Pharma PLC Transaction History